Seòmar agus comataidhean

Gateway Review teams normally speak with 12-15 interviewees including relevant commercial and external stakeholders (e.g. prime contractors and consultants). For the latest review, reviewers spoke to 45 people which included CSL, a range of producers, retailers, wholesaler, hospitality representatives, SEPA, Zero Waste Scotland and Scottish Government.

For this review, the interview team selected their chosen interviewees based on the information gathered from the previous gateway reviews as well as their understanding of Scotland’s Deposit Return Scheme (DRS).

The Scottish Government continues to engage with the Scottish Hospitality Group, and they attended a round table meeting with the First Minister and myself to discuss DRS on 20 April 2023.

The 16 August 2023 launch date of Scotland’s Deposit Return Scheme launch date was informed by a five month assessment process. This accounted for the findings of the Gateway Review conducted in June 2021 independent advice, review of Circularity Scotland’s implementation plans, and feedback from a wide range of stakeholders. This launch date was announced in Parliament on 14 December 2021.

Medicines used in prisons related to drug misuse and dependence will be made available in line with the UK-wide Guidelines on Clinical Management and should be approved for use by the Scottish Medicines Consortium. Records of medicines used in prisons are maintained by NHS National Services Scotland. From its records the list of medicines can be found below:

Methadone - Methadone is prescribed to prevent the illicit use of opiate and opioid drugs.

Buprenorphine –Buprenorphine is also prescribed to prevent the use of illicit opiate and opioid drugs.

Naltrexone –Naltrexone would be prescribed to prevent relapse use of opiate and opioids (not widely prescribed treatment).

Dihydrocodeine (DHC) – DHC is used as part of the safe management of withdrawal protocols. The objective of the DHC safe withdrawal symptom is to manage withdrawal symptoms and prevent patients from seeking opiates or opioids.

Diazepam – Diazepam is used as part of a safe management of withdrawal protocol for those who come into custody and have a positive urine test for a benzodiazepine. Diazepam is prescribed in a reducing dose protocol to safely manage withdrawals.

Acamprosate – is used to maintain abstinence in alcohol use in those who were previously heavy drinkers.

Disufiram – is an alcohol deterrent drug . Both acamprosate and disulfiram must be accompanied by appropriate supportive treatment.

The Deposit Return Scheme consumer campaign, which will be led by Circularity Scotland Ltd, has yet to begin. It will commence in the run up to the scheme’s launch next year to ensure consumers are aware of the launch date and how the scheme will work.

A detailed analysis of the composition of household waste and other available data has been undertaken and we aim to publish an updated food waste estimate in the coming months.

Our consultation on proposals for a Waste and Circular Economy Route Map set out proposed measures to accelerate progress towards our food waste reduction target, building on our 2019 Food Waste Reduction Action Plan. We will publish a review of progress and final Route Map later this year.

The Scottish Government has awarded over £205 million of regeneration funding to Clyde Gateway Urban Regeneration Company (URC) from 2007 to 2023 for the purpose of supporting the delivery of its 20-year operating plan. This includes direct support through annual capital and resource funding to develop and regenerate key sites identified in the plan, support core running costs and other activities it delivers in support of local communities.

Grant awards were made in each financial year are provided in the following table:

I refer the member to the answer to question S6W-16884 on 25 April 2023 All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers .

We understand how distressing and debilitating Multiple Sclerosis (MS) can be, and we want to ensure that all people living with the condition in Scotland are able to access the best possible care and support.

The Scottish Government has committed £1.95 million to the ‘Precision-MS: Integrating precision metrics of brain health into early treatment of Multiple Sclerosis’ study. The NHS Research Scotland Neuroprogressive Network are currently supporting 11 MS Research studies - to date 258 patients have been recruited to these.

We are working hard to deliver the commitments of our Neurological Care and Support Framework 2020-25 to ensure everyone with a neurological condition can access the care and support they need to live well, on their own terms.

Through the Framework we have invested over £300k in projects specifically to improve the health and wellbeing of people with MS in Scotland.

Police Scotland is reviewing the project’s timings as part of their wider planning for 2023/24 and beyond.

My predecessor met with the Assistant Chief Constable on 9 February on this matter, and whilst all those involved with delivering the National Dashcam Safety Portal remain committed to implementing this important safety initiative, I have asked my officials for an urgent update from Police Scotland on this matter.

Dumfries and Galloway Council were one of 165 organisations which responded to the consultation on the second Strategic Transport Projects Review (STPR2) draft report, undertaken between January and April 2022. The Council’s responses covered a range of topics, including potential improvements to the A75. All responses were considered in production of the suite of final reports and statutory impact assessments, published on 8 December 2022.